Country planning for health interventions under development: lessons from the malaria vaccine decision-making framework and implications for other new interventions
Open Access
- 17 April 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Health Policy and Planning
- Vol. 27 (uppl 2), ii50-ii61
- https://doi.org/10.1093/heapol/czs039
Abstract
Traditionally it has taken years or decades for new public health interventions targeting diseases found in developing countries to be accessible to those most in need. One reason for the delay has been insufficient anticipation of the eventual processes and evidence required for decision making by countries. This paper describes research into the anticipated processes and data needed to inform decision making on malaria vaccines, the most advanced of which is still in phase 3 trials. From 2006 to 2008, a series of country consultations in Africa led to the development of a guide to assist countries in preparing their malaria vaccine decision-making frameworks. The guide builds upon the World Health Organization’s Vaccine Introduction Guidelines. It identifies the processes and data for decisions, when they would be needed relative to the development timelines of the intervention, and where they will come from. Policy development will be supported by data (e.g. malaria disease burden; roles of other malaria interventions; malaria vaccine impact; economic and financial issues; malaria vaccine efficacy, quality and safety) as will implementation decisions (e.g. programmatic issues and socio-cultural environment). This generic guide can now be applied to any future malaria vaccine. The paper discusses the opportunities and challenges to early planning for country decision-making—from the potential for timely, evidence-informed decisions to the risks of over-promising around an intervention still under development. Careful and well-structured planning by countries is an important way to ensure that new interventions do not remain unused for years or decades after they become available.Keywords
This publication has 26 references indexed in Scilit:
- First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African ChildrenThe New England Journal of Medicine, 2011
- Supporting new vaccine introduction decisions: Lessons learned from the Hib Initiative experienceVaccine, 2010
- Health and economic impact of rotavirus vaccination in GAVI-eligible countriesBMC Public Health, 2010
- Informing decision makers: Experience and process of 15 National Immunization Technical Advisory GroupsVaccine, 2010
- Creating Access To Health Technologies In Poor CountriesHealth Affairs, 2009
- The Meningitis Vaccine ProjectVaccine, 2007
- Policymakers’ views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in AsiaVaccine, 2005
- The process of changing national malaria treatment policy: lessons from country-level studiesHealth Policy and Planning, 2004
- The importance of engaging policy-makers at the outset to guide research on and introduction of vaccines: the use of policy-maker surveys.2004
- Generalized cost-effectiveness analysis for national-level priority-setting in the health sectorCost Effectiveness and Resource Allocation, 2003